AU2015315173A1 - Substituted pyrrolidine compounds - Google Patents
Substituted pyrrolidine compounds Download PDFInfo
- Publication number
- AU2015315173A1 AU2015315173A1 AU2015315173A AU2015315173A AU2015315173A1 AU 2015315173 A1 AU2015315173 A1 AU 2015315173A1 AU 2015315173 A AU2015315173 A AU 2015315173A AU 2015315173 A AU2015315173 A AU 2015315173A AU 2015315173 A1 AU2015315173 A1 AU 2015315173A1
- Authority
- AU
- Australia
- Prior art keywords
- cancer
- cell
- tumor
- alkyl
- carcinoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462048757P | 2014-09-10 | 2014-09-10 | |
| US62/048,757 | 2014-09-10 | ||
| US201562146808P | 2015-04-13 | 2015-04-13 | |
| US62/146,808 | 2015-04-13 | ||
| PCT/US2015/049219 WO2016040504A1 (en) | 2014-09-10 | 2015-09-09 | Substituted pyrrolidine compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2015315173A1 true AU2015315173A1 (en) | 2017-03-16 |
Family
ID=55459527
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2015315173A Abandoned AU2015315173A1 (en) | 2014-09-10 | 2015-09-09 | Substituted pyrrolidine compounds |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20170253601A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3193604B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2017527577A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2015315173A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2960273A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2016040504A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112017004589A2 (pt) | 2014-09-10 | 2018-01-23 | Epizyme Inc | composto, composição farmacêutica, método para tratar um paciente, uso de um composto, kit, e método para tratar um distúrbio mediado por proteína smyd |
| AU2015315174B2 (en) | 2014-09-10 | 2019-12-12 | Epizyme, Inc. | Smyd inhibitors |
| WO2016040511A1 (en) | 2014-09-10 | 2016-03-17 | Epizyme, Inc. | Isoxazole carboxamides as irreversible smyd inhibitors |
| EP3190891B1 (en) | 2014-09-10 | 2020-01-15 | Epizyme, Inc. | Isoxazolecarboxamide substituted by a cyclohexylamine as smyd protein inhibitors |
| CA2960274A1 (en) | 2014-09-10 | 2016-03-17 | Epizyme, Inc. | Isoxazole carboxamide compounds |
| WO2018151678A1 (en) * | 2017-02-15 | 2018-08-23 | Agency For Science, Technology And Research | Compounds for treatment of cancer and epigenetics |
| KR102502046B1 (ko) * | 2018-01-26 | 2023-02-20 | 이도르시아 파마슈티컬스 리미티드 | Cxcr7 수용체 작동제 (3s,4s)-1-시클로프로필메틸-4-{[5-(2,4-디플루오로-페닐)-이속사졸-3-카르보닐]-아미노}-피페리딘-3-카르복실산 (1-피리미딘-2-일-시클로프로필)-아미드의 결정질 형태 |
| EP3986886A2 (en) | 2019-06-19 | 2022-04-27 | Grünenthal GmbH | Substituted pyrrolidine amides v |
| WO2025133989A1 (en) * | 2023-12-20 | 2025-06-26 | Alt-Bio Pte. Ltd. | Smyd modulators and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1287434A (en) * | 1918-05-16 | 1918-12-10 | Waterbury Mfg Co | Combined shade-holder and socket-cover. |
| HRP20120494T1 (hr) * | 2006-04-21 | 2012-08-31 | Novartis Ag | Derivati purina za uporabu kao agonista adenozin a2a receptora |
| US8048908B2 (en) * | 2006-07-13 | 2011-11-01 | High Point Pharmaceuticals, Llc | 11β-hydroxysteroid dehydrogenase type 1 active compounds |
| WO2014175370A1 (ja) * | 2013-04-25 | 2014-10-30 | 塩野義製薬株式会社 | ピロリジン誘導体およびそれらを含有する医薬組成物 |
-
2015
- 2015-09-09 JP JP2017513208A patent/JP2017527577A/ja active Pending
- 2015-09-09 AU AU2015315173A patent/AU2015315173A1/en not_active Abandoned
- 2015-09-09 US US15/510,602 patent/US20170253601A1/en not_active Abandoned
- 2015-09-09 CA CA2960273A patent/CA2960273A1/en not_active Abandoned
- 2015-09-09 WO PCT/US2015/049219 patent/WO2016040504A1/en not_active Ceased
- 2015-09-09 EP EP15840234.7A patent/EP3193604B1/en active Active
-
2019
- 2019-08-05 US US16/531,798 patent/US20200102314A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2017527577A (ja) | 2017-09-21 |
| US20200102314A1 (en) | 2020-04-02 |
| WO2016040504A1 (en) | 2016-03-17 |
| US20170253601A1 (en) | 2017-09-07 |
| EP3193604A4 (en) | 2018-02-21 |
| EP3193604A1 (en) | 2017-07-26 |
| EP3193604B1 (en) | 2021-06-16 |
| CA2960273A1 (en) | 2016-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022163087A (ja) | Smyd阻害剤 | |
| EP3193604B1 (en) | Substituted n-(pyrrolidin-3-yl)isoxazole-3-carboxamide compounds | |
| US10669243B2 (en) | Isoxazole carboxamides as irreversible SMYD inhibitors | |
| US10577363B2 (en) | Substituted piperidine compounds | |
| US20200048195A1 (en) | Substituted pyrrolidine carboxamide compounds | |
| US10428029B2 (en) | Isoxazole carboxamide compounds | |
| US10106510B2 (en) | Substituted isoxazoles for treating cancer | |
| US20200123142A1 (en) | Substituted Cyclohexylamine Compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |